Meli Pharm: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Meli Pharm
Largest movements
- Receivables within one year +€41,336
up €41,336 (+25.5%), from €162,336 to €203,672
of which Other amounts receivable: +€37,848
- Cash -€19,716
down €19,716 (-95.9%), from €20,552 to €836
mainly Receivables within one year (-€41,336) and Debts after one year (-€6,554)
- Tangible fixed assets -€9,282
down €9,282 (-31.7%), from €29,299 to €20,017
- Profit (loss) carried forward +€15,056
up €15,056 (+11.9%), from €126,549 to €141,605
- Debts after one year -€6,554
down €6,554 (-40.4%), from €16,239 to €9,685
- Trade debts +€4,068
up €4,068 (+174.5%), from €2,331 to €6,399
- Taxes +€1,700
up €1,700 (+40.5%), from €4,200 to €5,900
- Financial income +€1,257
up €1,257 (+17.3%), from €7,255 to €8,512
- Gross operating margin +€1,048
up €1,048 (+4.5%), from €23,142 to €24,190
- Other operating charges -€251
down €251 (-37.6%), from €668 to €417
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €212,187 | €224,525 | +€12,338 | +5.8% |
| Fixed assets | 21/28 | €29,299 | €20,017 | -€9,282 | -31.7% |
| Tangible fixed assets | 22/27 | €29,299 | €20,017 | -€9,282 | -31.7% |
| Furniture and vehicles | 24 | €29,299 | €20,017 | -€9,282 | -31.7% |
| Current assets | 29/58 | €182,888 | €204,508 | +€21,620 | +11.8% |
| Amounts receivable within one year | 40/41 | €162,336 | €203,672 | +€41,336 | +25.5% |
| Trade receivables | 40 | €15,694 | €19,182 | +€3,488 | +22.2% |
| Other amounts receivable | 41 | €146,642 | €184,489 | +€37,848 | +25.8% |
| Cash at bank and in hand | 54/58 | €20,552 | €836 | -€19,716 | -95.9% |
| Total equity and liabilities | 10/49 | €212,187 | €224,525 | +€12,338 | +5.8% |
| Equity | 10/15 | €151,237 | €166,293 | +€15,056 | +10.0% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €22,188 | €22,188 | = | 0.0% |
| Distributable reserves | 133 | €22,188 | €22,188 | = | 0.0% |
| Profit (loss) carried forward | 14 | €126,549 | €141,605 | +€15,056 | +11.9% |
| Amounts payable | 17/49 | €60,950 | €58,232 | -€2,718 | -4.5% |
| Amounts payable after more than one year | 17 | €16,239 | €9,685 | -€6,554 | -40.4% |
| Financial debts | 170/4 | €16,239 | €9,685 | -€6,554 | -40.4% |
| Amounts payable within one year | 42/48 | €44,710 | €48,546 | +€3,836 | +8.6% |
| Current portion of amounts payable after more than one year | 42 | €6,330 | €6,554 | +€225 | +3.5% |
| Financial debts | 43 | - | €752 | +€752 | |
| Credit institutions | 430/8 | - | €752 | +€752 | |
| Trade debts | 44 | €2,331 | €6,399 | +€4,068 | +174.5% |
| Suppliers | 440/4 | €2,331 | €6,399 | +€4,068 | +174.5% |
| Taxes, remuneration and social security | 45 | €36,050 | €34,841 | -€1,209 | -3.4% |
| Taxes | 450/3 | €36,050 | €9,308 | -€26,742 | -74.2% |
| Remuneration and social security | 454/9 | - | €25,533 | +€25,533 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,249 | €9,282 | +€33 | +0.4% |
| Other operating charges | 640/8 | €668 | €417 | -€251 | -37.6% |
| Gross operating margin | 9900 | €23,142 | €24,190 | +€1,048 | +4.5% |
| Operating profit (loss) | 9901 | €13,225 | €14,491 | +€1,266 | +9.6% |
| Financial income | 75/76B | €7,255 | €8,512 | +€1,257 | +17.3% |
| Recurring financial income | 75 | €7,255 | €8,512 | +€1,257 | +17.3% |
| Financial charges | 65/66B | €1,919 | €2,047 | +€127 | +6.6% |
| Recurring financial charges | 65 | €1,919 | €2,047 | +€127 | +6.6% |
| Profit (loss) for the period before taxes | 9903 | €18,560 | €20,956 | +€2,396 | +12.9% |
| Income taxes | 67/77 | €4,200 | €5,900 | +€1,700 | +40.5% |
| Profit (loss) for the period | 9904 | €14,360 | €15,056 | +€696 | +4.8% |
| Profit (loss) for the period to be appropriated | 9905 | €14,360 | €15,056 | +€696 | +4.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.